Alpha 2.0
Login Register
» Articles » PMID: 27047975

A Comparative Study of Serum, Urine and Saliva Using Rk39 Strip for the Diagnosis of Visceral Leishmaniasis

Overview
Journal J Arthropod Borne Dis
Publisher Tehran University of Medical Sciences
Date 2016 Apr 6
PMID 27047975
Citations 8
Authors
Sarita Mohapatra
Jyotish C Samantaray
Arnab Ghosh
Affiliations
Soon will be listed here.
Abstract

Background: Immunochromatographic based rk39 antibody detection test became popular for the diagnosis of visceral leishmaiasis (VL) because of high sensitivity, rapidity, easy to interpret, and cost effectiveness. However, false positive result after complete cure of the patients is the major limitation with this test. The aim of the study to access the usefulness of non-invasive samples i.e. urine and saliva by rk39 test for the diagnosis of visceral leishmaniasis in comparison to serum.

Methods: Seventy two clinically suspected VL patients were enrolled in the study among which 61 cases were confirmed as VL and 11 cases were included in the control group. Serum, urine, and saliva samples of all the cases were tested for rk39 dip stick test.

Results: Urine and saliva both were equally sensitive as serum for the diagnosis kala-azar. In the control group, rk39 antibody test was negative in 10 cases out 11 (91%) with saliva in comparison to 4 cases with serum (36%), thereby found to be more specific.

Conclusion: Saliva sample found to be highly reliable for the diagnosis of VL cases by rk39 test. The test with saliva sample showed less false positive result in comparison to serum sample, thereby can be used an adjunct with serum sample for the diagnosis of kala-azar in endemic areas.

Citing Articles

Can Wastewater Surveillance Enhance Genomic Tracking of Climate-Driven Pathogens?.

Van Poelvoorde L, Karlsson E, Dupont-Rouzeyrol M, Roosens N Microorganisms. 2025; 13(2).

PMID: 40005661 PMC: 11858121. DOI: 10.3390/microorganisms13020294.

Wearable biosensors for human fatigue diagnosis: A review.

Zhang J, Chen M, Peng Y, Li S, Han D, Ren S Bioeng Transl Med. 2023; 8(1):e10318.

PMID: 36684114 PMC: 9842037. DOI: 10.1002/btm2.10318.

Evaluation of urine sample for diagnosis of visceral leishmaniasis using rK-39 immunochromatographic test in Northwest Ethiopia.

Eyayu T, Yasin M, Workineh L, Tiruneh T, Andualem H, Sema M PLoS One. 2022; 17(2):e0263696.

PMID: 35130316 PMC: 8820633. DOI: 10.1371/journal.pone.0263696.

Evaluation of Cysteine Protease C of Leishmania donovani in Comparison with Glycoprotein 63 and Elongation Factor 1α for Diagnosis of Human Visceral Leishmaniasis and for Posttreatment Follow-Up Response.

Didwania N, Ejazi S, Chhajer R, Sabur A, Mazumder S, Kamran M J Clin Microbiol. 2020; 58(11).

PMID: 32848039 PMC: 7587114. DOI: 10.1128/JCM.00213-20.

Performance of rK39-based immunochromatographic rapid diagnostic test for serodiagnosis of visceral leishmaniasis using whole blood, serum and oral fluid.

Sanchez M, Celeste B, Lindoso J, Fujimori M, Pacheco de Almeida R, Fortaleza C PLoS One. 2020; 15(4):e0230610.

PMID: 32240188 PMC: 7117722. DOI: 10.1371/journal.pone.0230610.

References
1.
Kumar Haldar A, Sen P, Roy S . Use of antimony in the treatment of leishmaniasis: current status and future directions. Mol Biol Int. 2011; 2011:571242. PMC: 3196053. DOI: 10.4061/2011/571242. View
2.
Moody A . Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev. 2002; 15(1):66-78. PMC: 118060. DOI: 10.1128/CMR.15.1.66-78.2002. View
3.
Singh D, Pandey K, Das V, Das S, Kumar S, Topno R . Novel noninvasive method for diagnosis of visceral leishmaniasis by rK39 testing of sputum samples. J Clin Microbiol. 2009; 47(8):2684-5. PMC: 2725687. DOI: 10.1128/JCM.00988-09. View
4.
Khan M, Alam M, Podder M, Itoh M, Jamil K, Haque R . Evaluation of rK-39 strip test using urine for diagnosis of visceral leishmaniasis in an endemic area in Bangladesh. Parasit Vectors. 2010; 3:114. PMC: 3003646. DOI: 10.1186/1756-3305-3-114. View
5.
Huda M, Hirve S, Siddiqui N, Malaviya P, Banjara M, Das P . Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs. BMC Public Health. 2012; 12:1001. PMC: 3533526. DOI: 10.1186/1471-2458-12-1001. View